These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30122648)

  • 1. Assessment of one-dose mumps-containing vaccine effectiveness on wild-type genotype F mumps viruses circulating in mainland China.
    Cui A; Zhu Z; Mao N; Si Y; Ma Y; Hu Y; Deng X; Wang L; Zeng L; Zhang Y; Xu W
    Vaccine; 2018 Sep; 36(38):5725-5731. PubMed ID: 30122648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-neutralization between three mumps viruses & mapping of haemagglutinin-neuraminidase (HN) epitopes.
    Vaidya SR; Dvivedi GM; Jadhav SM
    Indian J Med Res; 2016 Jan; 143(1):37-42. PubMed ID: 26997012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection.
    Gouma S; Ten Hulscher HI; Schurink-van 't Klooster TM; de Melker HE; Boland GJ; Kaaijk P; van Els CACM; Koopmans MPG; van Binnendijk RS
    Vaccine; 2016 Jul; 34(35):4166-4171. PubMed ID: 27372154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-neutralization between vaccine and circulating wild-type mumps viruses in Korea.
    Won H; Kim AR; Yoo JS; Chung GT; Kang HJ; Kim SJ; Kim SS; Lee JW
    Vaccine; 2021 Mar; 39(13):1870-1876. PubMed ID: 33642163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies.
    Šantak M; Lang-Balija M; Ivancic-Jelecki J; Košutić-Gulija T; Ljubin-Sternak S; Forcic D
    Epidemiol Infect; 2013 Jun; 141(6):1298-309. PubMed ID: 22954346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sera from different age cohorts in Belgium show limited cross-neutralization between the mumps vaccine and outbreak strains.
    Vermeire T; Barbezange C; Francart A; Hamouda A; Litzroth A; Hutse V; Martens L; Vandermarliere E; Van Gucht S
    Clin Microbiol Infect; 2019 Jul; 25(7):907.e1-907.e6. PubMed ID: 30502489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and development of a promising novel mumps vaccine candidate strain.
    Liang Y; Ma S; Liu L; Zhao H; Wang L; Jiang L; Xie Z; Dong C; Li Q
    Microbes Infect; 2010 Dec; 12(14-15):1178-87. PubMed ID: 20800105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Virus strain specific serum neutralizing antibodies in children and adolescents immunized with a Russian mumps vaccine].
    Otrashevskaia EV; Krasil'nikov IV; Ignat'ev GM
    Vopr Virusol; 2010; 55(6):15-9. PubMed ID: 21381334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serologic Cross-Reactivity between the Mumps Virus Vaccine Genotype A Strain and the Circulating Genotype G Strain.
    Shaikh S; Carpenter M; Lin L; Frost JR; McLachlan E; Stein D; Van Caeseele P; Severini A
    Viruses; 2024 Sep; 16(9):. PubMed ID: 39339910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of mumps-containing vaccine effectiveness during an outbreak: Importance to introduce the 2-dose schedule for China.
    Ma C; Liu Y; Tang J; Jia H; Qin W; Su Y; Wang H; Hao L
    Hum Vaccin Immunother; 2018 Jun; 14(6):1392-1397. PubMed ID: 29377772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation on the short term effectiveness of two doses mumps-containing vaccine policy in Shandong, China].
    Xu Q; Xiong P; Fang XQ; Liu XD; Wang CY; Song LZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):265-270. PubMed ID: 29973005
    [No Abstract]   [Full Text] [Related]  

  • 12. [Functional state of specific immunity in children and teenagers vaccinated against mumps].
    Otrashevskaia EV; Bukin EK; Krasil'nikov IV; Ignat'ev GM
    Vopr Virusol; 2010; 55(4):20-5. PubMed ID: 20886708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of mumps virus vaccine candidates matching circulating genotypes in the United States and China.
    Zengel J; Phan SI; Pickar A; Xu P; He B
    Vaccine; 2017 Jul; 35(32):3988-3994. PubMed ID: 28623030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak.
    Rubin SA; Qi L; Audet SA; Sullivan B; Carbone KM; Bellini WJ; Rota PA; Sirota L; Beeler J
    J Infect Dis; 2008 Aug; 198(4):508-15. PubMed ID: 18558869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003.
    Atrasheuskaya AV; Blatun EM; Kulak MV; Atrasheuskaya A; Karpov IA; Rubin S; Ignatyev GM
    Vaccine; 2007 Jun; 25(24):4651-8. PubMed ID: 17498853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mumps outbreaks in a highly vaccinated population: Investigation of a neutralization titre against the current circulating wildtype genotype G5 mumps virus.
    Kenny L; O'Kelly E; Connell J; De Gascun C; Hassan J
    J Clin Virol; 2016 Jan; 74():8-12. PubMed ID: 26630067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An efficient, reproducible and accurate RT-qPCR based method to determine mumps specific neutralizing antibody.
    Sikazwe CT; Levy A; Speers D; Smith DW
    J Virol Methods; 2020 Mar; 277():113817. PubMed ID: 31911119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mumps Epidemiology and Mumps Virus Genotypes Circulating in Mainland China during 2013-2015.
    Cui A; Zhu Z; Hu Y; Deng X; Sun Z; Zhang Y; Mao N; Xu S; Fang X; Gao H; Si Y; Lei Y; Zheng H; He J; Wu H; Xu W
    PLoS One; 2017; 12(1):e0169561. PubMed ID: 28085897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and Safety of an F-Genotype Attenuated Mumps Vaccine in Healthy 8- to 24-Month-Old Children.
    Liang Y; Che Y; Yang B; Zhan F; Li H; Guan X; Zhang Y; Yin Q; Li C; Li J; Zhao Z; Liu L; Jiang G; Liao Y; Xu X; Ye J; Ren Q; He Y; Feng M; Wang L; Fan S; Cui X; Wang Z; Li C; Xiao H; Liu R; Li Q; Jiang C; Liu J; Li Q
    J Infect Dis; 2019 Jan; 219(1):50-58. PubMed ID: 30085178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel polyvalent live vaccine against varicella-zoster and mumps virus infections.
    Matsuura M; Somboonthum P; Murakami K; Ota M; Shoji M; Kawabata K; Mizuguchi H; Gomi Y; Yamanishi K; Mori Y
    Microbiol Immunol; 2013 Oct; 57(10):704-14. PubMed ID: 23905963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.